2026 3rd GLP (Cytotoxicity) Test Evaluation Certification Support Project (Mechanobiologically Active Materials Innovative Medical Device Demonstration Infrastructure)
Medical device SMEs can receive support for issuing official GLP cytotoxicity test certificates
- Eligible
- Small and medium-sized enterprises in the medical device industry
- Deadline
- 마감일 원문 확인
This project supports the issuance of official GLP (cytotoxicity) test evaluation certificates for SMEs and mid-sized companies in the medical device industry nationwide. The application period is from October 14 to October 20, 2026, with submissions accepted via email.
3-second summary
- Target: Nationwide small and medium-sized enterprises in the medical device industry
- Support: Issuance of official GLP (cytotoxicity) test/evaluation/certification certificates (Korean)
- Application Period: Oct 14, 2026 - Oct 20, 2026
- Application Method: Email submission (kimetjs@jbnu.ac.kr)
Schedule & how to apply
- Application Period: Oct 14, 2026 - Oct 20, 2026
- Application Method: Email submission (Must include '[GLP]' in the subject line)
Recommended for
- Recommended for CEOs of small and medium-sized enterprises in the medical device industry
Frequently asked questions
Who is eligible to apply?
This program is for Small and medium-sized enterprises in the medical device industry.
How do I apply?
Applications follow the official program notice, which is in Korean. See the source link for the method and receiving office; Beaconoi can prepare an English draft for your review.
Last updated · Source: official program notice
※ Program information is compiled from each institution’s public sources; actual eligibility, amounts and deadlines may change. Always verify against the official notice (in Korean) before applying.